Active substances
Aescin + Diethylamine salicylate
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| REPADERM GEL | 50,10 mg,mg | Gel · Topical | 1 Tube | SAR 26.50 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| REPADERM GEL | 50,10 mg,mg | Gel · Topical | 1 Tube | SAR 17.50 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| REPARIL GEL N | 5,1 %,g | Gel · Topical | 1 Tube | SAR 27.90 | NCE · Prescription | Viatris Healthcare GmbH | Valid |
| REPARIL GEL N | 5,1 %,g | Gel · Topical | 1 Tube | SAR 18.45 | NCE · Prescription | Viatris Healthcare GmbH | Valid |
Indications — CHI Daman Drug Formulary
LOW BACK PAIN
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.